Eloxx Pharmaceuticals Inc.

Greater London Legal Chronicle. May 17, 2024

Eloxx Pharmaceuticals’ Exclusive Licencing Agreement with Almirall

By Georgio Naffaa

In UK Gowling WLG, advised on the matter. Gowling WLG advised Eloxx Pharmaceuticals Inc. with a team including Patrick Duxbury (Picture – Life Science & Health...

This content is for members only.
Join Now

Already a member? Log in here

Takko Fashion GmbH’s €553 Million Refinancing

Surgical Science’s Acquisition of Intelligent Ultrasound Group

Republic of Ecuador’s US$1 Billion Debt Conversion Transaction

FirstGroup’s Acquisition Of RATP London

Kirkland Advises Blackstone on $1.5 Billion Investment in KKR

The Walt Disney Company’s $500 Million Senior Notes Offering

Cicada Solar Limited’s $10 Million Financing Round

Coigach Community Development Company’s Acquisition Of 7,900 Acres Of Tenanted Croft Land And Common Grazings

Robert P. Slight & Sons’ Sale to EOT

Gyrus Capital’s €600 Million Continuation Fund

RoundShield’s Closing of Private Credit Fund RS Fund V

Deep Blue’s Launch of the First Stablecoin of DBUSD in Jersey

Stevens & Bolton Bolsters Corporate Tax Practice With Lateral Hire

Charles Russell Speechlys Announces the Opening of a New Office in Italy

TLT Appoints Madi Dacwy as a Partner In Its Projects, Infrastructure and Construction Team

Eloxx Pharmaceuticals’ Exclusive Licencing Agreement with Almirall